Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $29.00 at Wedbush
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its price objective reduced by equities research analysts at ...
Sattva Sukun Consolidated December 2024 Net Sales at Rs 1.96 crore, up 29.05% Y-o-Y
Net Sales at Rs 1.96 crore in December 2024 up 29.05% from Rs. 1.52 crore in December 2023. Quarterly Net Profit at Rs. 0.69 ...